Form 4 for JAGX Jaguar Health, Inc.

Accepted 2022-04-06 00:00:00 ET · period of report 2022-04-05 · accession 0001104659-22-043245 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-04-06	2022-04-05	JAGX	Wolin Jonathan S.	CCO, GC, Chief of Staff	M - OptEx	—	+6,666	6,666	New	—
D	2022-04-06	2022-04-05	JAGX	Wolin Jonathan S.	CCO, GC, Chief of Staff	A - Grant	$0.00	+6,666	13.3K	+100%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-04-05	M	A	6,666	—	6,666	D	—	—	(F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) On September 8, 2021, the issuer effected a 3-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "Reverse Stock Split). Upon effectiveness of the Reverse Stock Split, every 3 shares of voting common stock was automatically converted into one share of voting common stock.
2	Derivative	Restricted stock units	2022-04-05	A	A	6,666	$0.00	13,333	D	— · — to —	6,666 Common Stock	(F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) On September 8, 2021, the issuer effected a 3-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "Reverse Stock Split). Upon effectiveness of the Reverse Stock Split, every 3 shares of voting common stock was automatically converted into one share of voting common stock. (F3) The restricted stock units were previously reported as covering 60,000 shares, but were adjusted to reflect the Reverse Stock Split. Such restricted stock units were granted on April 5, 2021 and vest in three equal annual installments beginning on April 5, 2022, the first anniversary of the grant date.